“…It tracks the signal changes after a passage of an administered contrast agent through rapid sequential imaging [ 10 , 108 ]. DCE could be used to assess the vascularity, perfusion, and vascular permeability of the pleural malignancies and predict their response to chemotherapy [ 1 , 11 , 16 , 17 , 74 , 75 , 82 , 107 , 108 , 112 , 115 , 116 , 117 ]. A two-compartment mathematical model may be used for pharmacokinetic analysis, to quantify the changes in microcirculation and judge vascular permeability [ 10 , 82 ].…”